for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Vcanbio Cell & Gene Engineering Corp Ltd

600645.SS

Latest Trade

17.55CNY

Change

0.04(+0.23%)

Volume

1,272,314

Today's Range

17.48

 - 

17.74

52 Week Range

14.52

 - 

23.97

As of on the Shanghai Stock Exchange ∙ Minimum 15 minute delay

Latest Developments

Vcanbio Cell & Gene Engineering Says Chairman Li Defu Resigns

Dec 7 (Reuters) - Vcanbio Cell & Gene Engineering Corp Ltd <600645.SS>::SAYS CHAIRMAN LI DEFU RESIGNS DUE TO CHANGE IN JOB ROLE.

Zhongyuan Union Cell & Gene Engineering Gets Regulatory Approval For Asset Acquisition

Aug 1 (Reuters) - Zhongyuan Union Cell & Gene Engineering Corp Ltd <600645.SS>::SAYS IT GETS SECURITIES REGULATOR'S APPROVAL FOR ASSET ACQUISITION.

Zhongyuan Union Cell & Gene Gets Approval For Asset Acquisition, Trading In Shares To Resume

June 6 (Reuters) - Zhongyuan Union Cell & Gene Engineering Corp Ltd <600645.SS>::SAYS IT GETS REGULATORY APPROVAL FOR ASSET ACQUISITION, TRADING IN SHARES TO RESUME ON JUNE 7.

Zhongyuan Union Cell Receives CFIUS Notice Regarding Its Plan To Indirectly Acquire Origene Technologies Inc

April 23 (Reuters) - Zhongyuan Union Cell & Gene Engineering Corp Ltd <600645.SS>::SAYS IT RECEIVES NOTICE FROM U.S. CFIUS THAT IT HAS COMPLETED THE REVIEW OF COMPANY'S ACQUISITION PROPOSAL TO INDIRECTLY ACQUIRE ORIGENE TECHNOLOGIES INC.

Zhongyuan Union Cell & Gene Engineering to sell its entire 67 pct stake in pharma tech firm for 60 mln yuan

March 2 (Reuters) - Zhongyuan Union Cell & Gene Engineering Corp Ltd <600645.SS> ::Says it plans to sell its entire 67 percent stake in a Zhejiang-based pharma tech firm for 60 million yuan .

Zhongyuan Union Cell & Gene Engineering To Sell Stake In Genetic Research Firm

Feb 5 (Reuters) - Zhongyuan Union Cell & Gene Engineering Corp Ltd <600645.SS>::SAYS IT PLANS TO SELL 6.48 PERCENT STAKE IN GENETIC RESEARCH FIRM FOR 125 MILLION YUAN ($19.89 million).

Zhongyuan Union Cell & Gene Engineering says individual to add stake in co within 6 months

Feb 2 (Reuters) - Zhongyuan Union Cell & Gene Engineering Corp Ltd <600645.SS> ::Says an individual Gong Hongjia plans to add at least 3 percent or no more than 5 percent stake of shares of the company within 6 months since Feb. 2.

Zhongyuan Union Cell & Gene Engineering To Buy Shanghai Firm for 1.2 Bln Yuan

Jan 4 (Reuters) - Zhongyuan Union Cell & Gene Engineering Corp Ltd <600645.SS>::SAYS TO BUY SHANGHAI-BASED MEDICAL EQUIPMENT FIRM FOR 1.2 BILLION YUAN ($184.79 million) VIA SHARE ISSUE.SAYS IT AIMS TO RAISE UP TO 500 MILLION YUAN IN PRIVATE PLACEMENT OF SHARES TO FUND PROJECTS.

Zhongyuan Union Cell & Gene Engineering unit liquidates Tianjin-based hospital management firm

Nov 30 (Reuters) - Zhongyuan Union Cell & Gene Engineering Co Ltd <600645.SS>:Says its unit liquidated Tianjin-based hospital management firm .

Zhongyuan Union Cell & Gene Engineering to sell stake in pharmaceutical tech firm for 60 mln yuan

Nov 27 (Reuters) - Zhongyuan Union Cell & Gene Engineering Co Ltd <600645.SS> ::Says it plans to sell 67 percent stake in a Zhejiang-based pharmaceutical tech firm, for 60 million yuan .

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up